OncoMed Pharma (OMED) Misses Q2 EPS by 10c

August 9, 2016 5:09 PM EDT
Get Alerts OMED Hot Sheet
Trade OMED Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

OncoMed Pharma (NASDAQ: OMED) reported Q2 EPS of ($0.91), $0.10 worse than the analyst estimate of ($0.81). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $8.09 million.

For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment